Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K/BxN serum-transfer arthritis model

Arthritis Research and Therapy

Volumn 12, Issue 6, 2010, Pages

  García, Samuel ^a   Forteza, Jerónimo ^a   López Otin, Carlos ^b   Gómez Reino, Juan J ^a,c   González, Antonio ^a   Conde, Carmen ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 1BETA; NEUTROPHIL COLLAGENASE; PENTRAXIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTHRITIS; ARTICLE; BONE EROSION; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DNA MICROARRAY; ENZYME DEFICIENCY; FEMALE; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SYNOVITIS; WESTERN BLOTTING; ANIMAL; BONE; C57BL MOUSE; DISEASE MODEL; ENZYMOLOGY; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; TRANSGENIC MOUSE;

ANIMALS; ANKLE JOINT; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; BONE AND BONES; DISEASE MODELS, ANIMAL; INFLAMMATION; MATRIX METALLOPROTEINASE 8; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78650612276     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3211     Document Type: Article

References (42)

1. Sweeney SE, Firestein GS. Rheumatoid arthritis: regulation of synovial inflammation. Int J Biochem Cell Biol 2004, 36:372-378. 10.1016/S1357-2725(03)00259-0, 14687914.
2. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007, 7:429-442. 10.1038/nri2094, 17525752.
3. Takaishi H, Kimura T, Dalal S, Okada Y, D'Armiento J. Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr Pharm Biotechnol 2008, 9:47-54. 10.2174/138920108783497659, 18289056.
4. Rengel Y, Ospelt C, Gay S. Proteinases in the joint: clinical relevance of proteinases in joint destruction. Arthritis Res Ther 2007, 9:221. 10.1186/ar2304, 2212555, 18001502.
5. Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, Okada Y. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid artrhritis or osteoarthritis. Ann Rheum Dis 2000, 59:455-461. 10.1136/ard.59.6.455, 1753174, 10834863.
6. Tchetverikov I, Lard LR, DeGroot J, Verzijl N, TeKoppele JM, Breedveld FC, Huizinga TW, Hanemaaijer R. Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis. Ann Rheum Dis 2003, 62:1094-1099. 10.1136/ard.62.11.1094, 1754368, 14583574.
7. Tolboom TC, Pieterman E, van der Laan WH, Toes RE, Huidekoper AL, Nelissen RG, Breedveld FC, Huizinga TW. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Ann Rheum Dis 2002, 61:975-980. 10.1136/ard.61.11.975, 1753950, 12379519.
8. Green MJ, Gough AK, Devlin J, Smith J, astin P, Taylor D, Emery P. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology 2003, 42:83-88. 10.1093/rheumatology/keg037, 12509618.
9. Itoh T, matsuda H, Tanioka M, Kuwabara K, Itohara S, Suzuki R. The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J Immunol 2002, 169:2643-2647.
10. van Meurs J, Van Lent P, Stoop R, Holthuysen A, Singer I, Bayne E, Mudgett J, Poole R, Billinghurst C, Van der Kraan P, Burna P, Van den Berg W. Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity. Arthritis Rheum 1999, 42:2074-2084. 10.1002/1529-0131(199910)42:10<2074::AID-ANR7>3.0.CO;2-5, 10524678.
11. Mudgett JS, Hutchinson NI, Chartrain NA, Forsyth AJ, Mcdonnell J, Sdinger II, Bayne EK, Flanagan J, Kawka D, Shen CF, Stevens K, Chen H, Trumbauer M, Visco DM. Susceptibility of stromelysin-1-deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum 1998, 41:110-121. 10.1002/1529-0131(199801)41:1<110::AID-ART14>3.0.CO;2-G, 9433876.
12. Cole AA, Chubinskaya S, Schumacher B, Huch K, Szabo G, Yao J, Mikecz K, Hasty KA, Kuettner KE. Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase. J Biol Chem 1996, 271:11023-11026. 10.1074/jbc.271.18.11023, 8631924.
13. Hanemaaijer R, Sorsa T, Konttinen YT, Ding Y, Sutinen M, Visser H, van Hinsbergh VW, Helaakoski T, Kainulainen T, Rönkä H, Tschesche H, Salo T. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem 1997, 272:31504-31509. 10.1074/jbc.272.50.31504, 9395486.
14. van Lint P, Wielockx B, Puimège L, Nöel A, López-Otin C, Libert C. Resistance of collagenase-2 (matrix metalloproteinase-8)-deficient mice to TNF-induced lethal hepatitis. J Immunol 2005, 175:7642-7649.
15. Tester AM, Cox JH, Connor AR, Starr AE, Dean RA, Puente XS, López-Otin C, Overall CM. LPS responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity. PloS ONE 2007, 2:e312. 10.1371/journal.pone.0000312, 1819564, 17375198.
16. Gutiérrez-Fernández A, Inada M, Balbín M, Fueyo A, Pitiot AS, Astudillo A, Hirose K, Hirata M, Shapiro SD, Noël A, Werb Z, Krane SM, López-Otin C, Puente XS. Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8). FASEB J 2007, 21:2580-2591. 2575772, 17392479.
17. Gueders MM, Balbin M, Rocks N, Foidart JM, Gosset P, Louis R, Shapiro S, Lopez-Otin C, Noël A, Cataldo DD. Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammation. J Immunol 2005, 175:2589-2597.
18. van den Steen PE, Husson SJ, Proost P, Van Damme J, Opdenakker G. Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase. Biochem Biophys Res Commun 2003, 310:889-896. 10.1016/j.bbrc.2003.09.098, 14550288.
19. Balbín M, Fueyo A, Tester AM, Pendás AM, Pitiot AS, Astudillo A, Overall CM, Shapiro SD, López-Otín C. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet 2003, 35:252-257.
20. Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell 1996, 87:811-822. 10.1016/S0092-8674(00)81989-3, 8945509.
21. García S, Bodaño A, González A, Forteza J, Gomez-Reino JJ, Conde C. Partial protection against collagen antibody-induced arthritis in PARP-1 deficient mice. Arthritis Res Ther 2006, 8:R14. 1526570, 16356201.
22. Scatizzi JC, Bickel E, Hutcheson J, Haines GK, Perlman H. Bim deficiency leads to exacerbation and prolongation of joint inflammation in experimental arthritis. Arthritis Rheum 2006, 54:3182-3193. 10.1002/art.22133, 17009248.
23. Pettit AR, Ji H, von Stechow D, Müller R, Goldring SR, Choi Y, Benoist C, Gravallese EM. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 2001, 159:1689-1699. 1867076, 11696430.
24. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nat Protoc 2009, 4:44-57. 10.1038/nprot.2008.211, 19131956.
25. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4:P3. 10.1186/gb-2003-4-5-p3, 12734009.
26. Edgar R, Domrachev M, Lash AE. Gene expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acid Res 2002, 30:207-210. 10.1093/nar/30.1.207, 99122, 11752295.
27. Gene Expression Omnibus series accession number. , http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE22971
28. Close DR. Matrix metalloproteinase inhibitors in rheumatic diseases. Ann Rheum Dis 2001, 60:iii62-iii67. 1766680, 11890658.
29. Clark IM, Parker AE. Metalloproteinases: their role in arthritis and potential as therapeutic targets. Expert Opin Ther Targets 2003, 7:19-34. 10.1517/14728222.7.1.19, 12556200.
30. Brennan FM, McInnes IB. Evidence that cytokines plays a role in rheumatoid arthritis. J Clin Invest 2008, 118:3537-3545. 10.1172/JCI36389, 2575731, 18982160.
31. Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, Ikuse T, Asano M, Iwakura Y. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 2000, 191:313-320. 10.1084/jem.191.2.313, 2195765, 10637275.
32. Hata H, Sakaguchi N, Yoshitomi H, Iwakura Y, Sekikawa K, Azuma Y, Kanai C, Moriizumi E, Nomura T, Nakamura T, Sakaguchi S. Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest 2004, 114:582-588. 503774, 15314695.
33. Ji H, Pettit A, Ohmura K, Ortiz-Lopez A, Duchatelle V, Degott C, Gravallese E, Mathis D, Benoist C. Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J Exp Med 2002, 196:77-85. 10.1084/jem.20020439, 2194010, 12093872.
34. Choe JY, Crain B, Wu SR, Corr M. Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling. J Exp Med 2003, 197:537-542. 10.1084/jem.20021850, 2193870, 12591910.
35. Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL. IL-1 mediated TNF-induced osteoclastogenesis. J Clin Invest 2005, 115:282-290. 544608, 15668736.
36. Zwerina J, Redlich K, Polzer K, Joosten L, Krönke G, Distler J, Hess A, Pundt N, Pap T, Hoffmann O, Gasser J, Scheinecker C, Smolen JS, van den Berg W, Schett G. TNF-induced structural joint damage is mediated by IL-1. Proc Natl Acad Sci USA 2007, 104:11742-11747. 10.1073/pnas.0610812104, 1913858, 17609389.
37. Manfredi AA, Rovere-Querini P, Bottazzi B, Garlanda C, Mantovani A. Pentraxins, humoral innate immunity and tissue injury. Curr Opin Immunol 2008, 20:538-544. 10.1016/j.coi.2008.05.004, 18579363.
38. Luchetti MM, Piccinini G, Mantovani A, Peri G, Mattencci C, Pomponio G, Fratini M, Fraticelli P, Sambo P, DiLoreto C, Introna M, Gabrielli A. Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA). Clin Exp Immunol 2000, 119:196-202. 10.1046/j.1365-2249.2000.01110.x, 1905539, 10606983.
39. Souza DG, Soares AC, Pinho V, Torloni H, Reis LFL, Martins MT, Dias AAM. Increased mortality and inflammation in tumor necrosis factor-stimulated gene-14 transgenic mice after ischemia and reperfusion injury. Am J Pathol 2002, 160:1755-1765. 1850862, 12000727.
40. Deban L, Russo RC, Sironi M, Moalli F, Scanziani M, Zambelli V, Cuccovillo I, Bastone A, Gobbi M, Valentino S, Doni A, Garlanda C, Danese S, Salvatori G, Sassano M, Evangelista V, Rossi B, Zenaro E, Constantin G, Laudanna C, Bottazzi B, Mantovani A. Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat Immunol 2010, 11:328-334. 10.1038/ni.1854, 20208538.
41. LeCouter J, Zlot C, Tejada M, Peale F, Ferrara N. Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. Proc Natl Acad Sci USA 2004, 101:16813-16818. 10.1073/pnas.0407697101, 528996, 15548611.
42. Monnier J, Samson M. Cytokine properties of prokineticins. FEBS J 2008, 275:4014-4021. 10.1111/j.1742-4658.2008.06559.x, 18647349.